Cargando…

Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes

PURPOSE: Optimal glycemic control is crucial for proper wound healing in patients with diabetes. However, it is not clear whether other antidiabetic drugs support wound healing in mechanisms different from the normalization of blood glucose control. We assessed the effect of insulin and metformin ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Mieczkowski, Mateusz, Mrozikiewicz-Rakowska, Beata, Siwko, Tomasz, Bujalska-Zadrozny, Magdalena, de Corde-Skurska, Anna, Wolinska, Renata, Gasinska, Emilia, Grzela, Tomasz, Foltynski, Piotr, Kowara, Michal, Mieczkowska, Zofia, Czupryniak, Leszek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039538/
https://www.ncbi.nlm.nih.gov/pubmed/33854349
http://dx.doi.org/10.2147/DMSO.S296287
_version_ 1783677613551648768
author Mieczkowski, Mateusz
Mrozikiewicz-Rakowska, Beata
Siwko, Tomasz
Bujalska-Zadrozny, Magdalena
de Corde-Skurska, Anna
Wolinska, Renata
Gasinska, Emilia
Grzela, Tomasz
Foltynski, Piotr
Kowara, Michal
Mieczkowska, Zofia
Czupryniak, Leszek
author_facet Mieczkowski, Mateusz
Mrozikiewicz-Rakowska, Beata
Siwko, Tomasz
Bujalska-Zadrozny, Magdalena
de Corde-Skurska, Anna
Wolinska, Renata
Gasinska, Emilia
Grzela, Tomasz
Foltynski, Piotr
Kowara, Michal
Mieczkowska, Zofia
Czupryniak, Leszek
author_sort Mieczkowski, Mateusz
collection PubMed
description PURPOSE: Optimal glycemic control is crucial for proper wound healing in patients with diabetes. However, it is not clear whether other antidiabetic drugs support wound healing in mechanisms different from the normalization of blood glucose control. We assessed the effect of insulin and metformin administration on the wound healing process in rats with streptozotocin-induced diabetes. METHODS: The study was conducted on 200 male Wistar rats with streptozotocin-induced diabetes. In the last phase of the study, 45 rats, with the most stable glucose levels in the range of 350–500 mg/dL, were divided into three groups: group I received human non-protamine insulin subcutaneously (5 IU/kg body mass) once a day, group II received metformin intragastrically (500 mg/kg b.m.), and group III (control) was given saline subcutaneously. After 14 days of antidiabetic treatment, a 2 cm × 2 cm thin layer of skin was cut from each rat’s dorsum and a 4 cm disk with a hole in its center was sewn in to stabilize the skin and standardize the healing process. The wound healing process was followed up for 9 days, with assessment every 3 days. Biopsy samples were subjected to hematoxylin and eosin staining and immunohistochemical assays. RESULTS: Analysis of variance revealed significant influence of treatment type (insulin, control, or metformin) on the relative change in wound surface area. The wound healing process in rats treated with insulin was more effective than in the metformin and control groups. Wound tissue samples taken from the insulin-treated animals presented significantly lower levels of inflammatory infiltration. Immunohistochemical assessment showed the greatest density of centers of proliferation Ki-67 in insulin-treated animals. CONCLUSION: These results suggest that an insulin-based treatment is more beneficial than metformin, in terms of accelerating the wound healing process in an animal model of streptozocin-induced diabetes.
format Online
Article
Text
id pubmed-8039538
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-80395382021-04-13 Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes Mieczkowski, Mateusz Mrozikiewicz-Rakowska, Beata Siwko, Tomasz Bujalska-Zadrozny, Magdalena de Corde-Skurska, Anna Wolinska, Renata Gasinska, Emilia Grzela, Tomasz Foltynski, Piotr Kowara, Michal Mieczkowska, Zofia Czupryniak, Leszek Diabetes Metab Syndr Obes Original Research PURPOSE: Optimal glycemic control is crucial for proper wound healing in patients with diabetes. However, it is not clear whether other antidiabetic drugs support wound healing in mechanisms different from the normalization of blood glucose control. We assessed the effect of insulin and metformin administration on the wound healing process in rats with streptozotocin-induced diabetes. METHODS: The study was conducted on 200 male Wistar rats with streptozotocin-induced diabetes. In the last phase of the study, 45 rats, with the most stable glucose levels in the range of 350–500 mg/dL, were divided into three groups: group I received human non-protamine insulin subcutaneously (5 IU/kg body mass) once a day, group II received metformin intragastrically (500 mg/kg b.m.), and group III (control) was given saline subcutaneously. After 14 days of antidiabetic treatment, a 2 cm × 2 cm thin layer of skin was cut from each rat’s dorsum and a 4 cm disk with a hole in its center was sewn in to stabilize the skin and standardize the healing process. The wound healing process was followed up for 9 days, with assessment every 3 days. Biopsy samples were subjected to hematoxylin and eosin staining and immunohistochemical assays. RESULTS: Analysis of variance revealed significant influence of treatment type (insulin, control, or metformin) on the relative change in wound surface area. The wound healing process in rats treated with insulin was more effective than in the metformin and control groups. Wound tissue samples taken from the insulin-treated animals presented significantly lower levels of inflammatory infiltration. Immunohistochemical assessment showed the greatest density of centers of proliferation Ki-67 in insulin-treated animals. CONCLUSION: These results suggest that an insulin-based treatment is more beneficial than metformin, in terms of accelerating the wound healing process in an animal model of streptozocin-induced diabetes. Dove 2021-04-06 /pmc/articles/PMC8039538/ /pubmed/33854349 http://dx.doi.org/10.2147/DMSO.S296287 Text en © 2021 Mieczkowski et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mieczkowski, Mateusz
Mrozikiewicz-Rakowska, Beata
Siwko, Tomasz
Bujalska-Zadrozny, Magdalena
de Corde-Skurska, Anna
Wolinska, Renata
Gasinska, Emilia
Grzela, Tomasz
Foltynski, Piotr
Kowara, Michal
Mieczkowska, Zofia
Czupryniak, Leszek
Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes
title Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes
title_full Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes
title_fullStr Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes
title_full_unstemmed Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes
title_short Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes
title_sort insulin, but not metformin, supports wound healing process in rats with streptozotocin-induced diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039538/
https://www.ncbi.nlm.nih.gov/pubmed/33854349
http://dx.doi.org/10.2147/DMSO.S296287
work_keys_str_mv AT mieczkowskimateusz insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes
AT mrozikiewiczrakowskabeata insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes
AT siwkotomasz insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes
AT bujalskazadroznymagdalena insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes
AT decordeskurskaanna insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes
AT wolinskarenata insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes
AT gasinskaemilia insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes
AT grzelatomasz insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes
AT foltynskipiotr insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes
AT kowaramichal insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes
AT mieczkowskazofia insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes
AT czupryniakleszek insulinbutnotmetforminsupportswoundhealingprocessinratswithstreptozotocininduceddiabetes